
	Cellular Biomedicine Group (OTCQB: CBMG) is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. We are the result of the acquisition, transfer, commercialization and advancement of thirty years of research and human treatment experience in cellular medicine. Our cellular research and development comes from collaboration among scientists and doctors from the US, England and China.
	
	CBMG has been actively developing technologies and products based on defensible intellectual property.
